NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Umeå University
Conditions: Health of Formula-fed Children, Infant Infections in Formula-fed Children, Iron Status of Formula-fed Children
Interventions: Formula with low iron concentration (2 mg/L) supplemented with bovine lactoferrin, Formula with low iron concentration (2mg/L) without lactoferrin, Formula with normal iron concentration (8 mg/L) without lactoferrin
Countries: Sweden
Breast milk is the gold standard of early infant nutrition and breastfed infants have advantages in several short and long term outcomes compared to those formula-fed. The first aim of this study is to evaluate the effect of adding bovine lactoferrin to infant formula. The general hypothesis is that bovine lactoferrin reduces some of the previously observed differences between formula-fed and breast-fed infants with regard to health and development. The main outcome studied is the effect on immune function. The second aim is to study the effects of lower iron concentration in infant formula and to test the hypothesis that iron can be lowered without negative effects on health and development. The main outcome studied here is iron status. Other outcomes in this trial are microbiota composition, metabolomics, growth, body composition and cognitive development. To test the lactoferrin hypothesis, formula-fed infants will be recruited and fed a low iron (2 mg/L) control formula, or the same formula supplemented with bovine lactoferrin. To test the iron hypothesis, a third group will be fed the same formula (no lactoferrin) with higher iron concentration (8 mg/L). Group allocation for all formula-fed infants will be double-blind randomized. Additionally, breast-fed infants will be recruited and used as a reference group (gold standard).
Sex: ALL
Age: 4 Weeks to 8 Weeks
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Inclusion Criteria: Formula-fed healthy infants at 6 +/- 2 weeks of age with: * birth weight 2500-4500 g * gestational age at birth ≥ 37 completed weeks * no chronic disease or neonatal diagnoses believed to affect any outcome * no given blood transfusions or iron supplements Exclusion Criteria: \-
- Umeå, Sweden